Weekly 24 h infusion of aviscumine (rViscumin): a phase I study in patients with solid tumours.
about
Mistletoe therapy in oncologySafety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parametersTriterpenoids amplify anti-tumoral effects of mistletoe extracts on murine B16.f10 melanoma in vivoClinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancerDifferences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.Intravenous Mistletoe Treatment in Integrative Cancer Care: A Qualitative Study Exploring the Procedures, Concepts, and Observations of Expert Doctors.Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical researchAviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cells.
P2860
Q24243314-B3C7D226-475C-4F73-A66C-7F09C15B839BQ27002602-9F9C4A04-9757-49BD-8744-A1B5E68C0ACAQ27323005-23BB7C9B-759B-4D62-BCFF-588E6B1C5323Q30372504-64A2F32C-725D-48AE-80B5-D22812A2D66AQ33767713-ADF182F3-B885-4C62-B195-673B67059570Q36880805-39FE71FB-7A0D-40AC-B624-6BCFF0DC2201Q37262806-60B874A0-CEA8-4A3C-B85D-F42911E679E5Q44389468-E3963B6A-E332-4544-9E17-C1153800C9CC
P2860
Weekly 24 h infusion of aviscumine (rViscumin): a phase I study in patients with solid tumours.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Weekly 24 h infusion of aviscu ...... n patients with solid tumours.
@ast
Weekly 24 h infusion of aviscu ...... n patients with solid tumours.
@en
type
label
Weekly 24 h infusion of aviscu ...... n patients with solid tumours.
@ast
Weekly 24 h infusion of aviscu ...... n patients with solid tumours.
@en
prefLabel
Weekly 24 h infusion of aviscu ...... n patients with solid tumours.
@ast
Weekly 24 h infusion of aviscu ...... n patients with solid tumours.
@en
P2093
P1476
Weekly 24 h infusion of aviscu ...... n patients with solid tumours.
@en
P2093
Breidenbach I
Schöffski P
Wilhelm-Ogunbiyi K
P304
P356
10.1016/J.EJCA.2005.03.019
P577
2005-07-01T00:00:00Z